James Reinprecht
Internal Medicine · Rockledge, PANPI 1053317438
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 88 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 20.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,136 and has fallen 97.2% since, to $32 in 2023.
Across 88 payments — averaging $15.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$271
- Novo Nordisk$212
- AbbVie$186
- Amgen$111
- Lilly USA, LLC$78
- Astellas Pharma US Inc$76
- plus $416 from 15 others
What the payments were for
- Food & beverage$1,350100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 16 | $271 |
| Novo Nordisk | 14 | $212 |
| AbbVie(2 entities) | 14 | $186 |
| Amgen | 5 | $111 |
| Lilly USA, LLC | 5 | $78 |
| Astellas Pharma US Inc | 5 | $76 |
| Johnson & Johnson(2 entities) | 5 | $65 |
| Merck | 5 | $60 |
| AstraZeneca | 4 | $51 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $31 |
| GSK | 1 | $29 |
| Teva Pharmaceuticals USA, Inc. | 2 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $22 |
| Genentech USA, Inc. | 1 | $21 |
| IBSA Pharma Inc. | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Eisai Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Sunovion Pharmaceuticals Inc. | 1 | $12 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
How this compares
$1,350 in reported general payments places this provider in the 80th percentile of 5,705 internal medicine providers in Pennsylvania.
Other internal medicine in Rockledge
- Jonathan EpsteinPhiladelphia$13.1M
- Pitamber DevgonPhiladelphia$7.5M
- Daniel RaderPhiladelphia$1.7M
- Mohammed KidwaiBala Cynwyd$894K
- Ronak BhimaniNorristown$623K
- David GoldmannPhiladelphia$525K
- Christopher StillDanville$442K
- Jeffrey FreidLower Gwynedd$425K
- Cheryl PegusSpring House$370K
- Eyob FeyssaPhiladelphia$328K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.